Serial Number
87013993
Owner
ACADIA Pharmaceuticals Inc.Attorney
Brian FocarinoFirst Use Date
Jul 30, 2018
Filing Date
Apr 26, 2016
NUPLAZIDCONNECT Trademark
Serial Number: 87013993 • Registration: 5997331
Trademark Classes
Class 36 - Insurance & Financial
Insurance; financial affairs; monetary affairs; real estate affairs
Class 41 - Education & Entertainment
Education; providing of training; entertainment; sporting and cultural activities
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Class 16 - Paper Goods
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Class 35 - Advertising & Business
Advertising; business management; business administration; office functions
Owner Contact Info
Legal Representation
Correspondence Address
Brian Focarino Cooley LLP
1299 Pennsylvania Avenue, NW, Suite 700
ATTN: IP Docketing Department
Washington, DC 20004-2400
United States
Trademark Details
Filing Date
April 26, 2016
Registration Date
February 25, 2020
First Use Anywhere
July 30, 2018
First Use in Commerce
July 30, 2018
Published for Opposition
November 15, 2016
Goods & Services
Educational services, namely, conducting educational programs about neurologic, metabolic, and genetic diseases and disorders and treatment and patient support options for these conditions
Publications in the nature of brochures, pamphlets, newsletters, articles and guidebooks in the field of medical information and patient support
Providing a website featuring financial information regarding medical benefits and reimbursements available for medical expenses related thereto; insurance services, namely, benefits verification; providing online information for health care providers and patients in the field of neurologic, metabolic and genetic diseases and disorders, namely, information and assistance with insurance benefits and coverage
Promoting awareness of patient support offerings for neurologic, metabolic, and genetic diseases and disorders; business administration of reimbursement and medical benefit information for neurologic, metabolic and genetic conditions and their treatment; medical referrals
Medical consulting with respect to neurologic, metabolic, and genetic conditions and their treatment; providing online information for health care providers and patients in the field of neurologic, metabolic and genetic diseases and disorders; medical informational support services, namely, providing information about the therapeutic benefits of pharmaceutical products, medical information regarding disease management, and healthcare-related information to patients and healthcare professionals all related to neurologic, metabolic and genetic diseases and disorders
